RPL32 and cancer: To evaluate the expression pattern of RPL32 in a pan‐cancer manner, we performed bioinformatics analysis on TNMplot, TIMER, and GTEx (coupled with TCGA) databases, and found that RPL32 was highly expressed in a large proportion of cancers (Figure S1A–C), indicating RPL32 is an oncogene.